STOCK TITAN

Lilly to participate in TD Cowen's 46th Annual Health Care Conference

Eli Lilly and Company (NYSE:LLY) will participate in TD Cowen's 46th Annual Health Care Conference on March 2, 2026.

(Neutral)
(Neutral)
Tags

Eli Lilly and Company (NYSE:LLY) will participate in TD Cowen's 46th Annual Health Care Conference on March 2, 2026. Lucas Montarce, executive vice president and chief financial officer, will appear in a fireside chat at 3:10 p.m. ET.

A live audio webcast will be available via Lilly's investor site under Webcasts & Presentations, with a replay accessible on the same site for approximately 90 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Session date unavailable
-0.38% session move Open Argus
Details

News Market Reaction – LLY

The recorded move for LLY in the trading session of this news was -0.38%.

Data tracked by StockTitan Argus. Session date unavailable.

Market Context

This announcement highlights Eli Lilly’s participation in TD Cowen’s 46th Annual Health Care Confere...
Analysis

This announcement highlights Eli Lilly’s participation in TD Cowen’s 46th Annual Health Care Conference, with a 3:10 p.m. Eastern fireside chat and a webcast replay available for 90 days. Set against recent major events—earnings, an acquisition agreement, FDA Breakthrough Therapy designation, and large manufacturing investments—the news primarily reflects ongoing investor engagement. Observers may focus on whether commentary at the conference elaborates on prior guidance, pipeline milestones, and capital deployment plans.

Key Figures

Conference date: March 2, 2026 Conference edition: 46th Presentation time: 3:10 p.m. Eastern +1 more
Conference date
March 2, 2026
TD Cowen's 46th Annual Health Care Conference
Conference edition
46th
TD Cowen Annual Health Care Conference
Presentation time
3:10 p.m. Eastern
Scheduled fireside chat at conference
Replay availability
90 days
Replay on Lilly's investor website

Historical Context

5 past events · Latest: Feb 09
5 events
  1. Feb 09

    Acquisition announcement

    24h Move
    -1.3%

    Agreement to acquire Orna Therapeutics for up to $2.4B in cash.

  2. Feb 04

    Earnings and guidance

    24h Move
    +10.3%

    Q4 2025 results and 2026 guidance with strong revenue and EPS outlook.

  3. Jan 30

    Capacity expansion

    24h Move
    +1.3%

    More than $3.5B commitment to new injectable medicine facility.

  4. Jan 21

    Earnings call date

    24h Move
    +3.6%

    Set date and webcast details for Q4 2025 results call.

  5. Jan 20

    Regulatory milestone

    24h Move
    +0.3%

    FDA Breakthrough Therapy designation for sofetabart mipitecan in ovarian cancer.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

INDIANAPOLIS, Feb. 16, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in TD Cowen's 46th Annual Health Care Conference on March 2, 2026. Lucas Montarce, executive vice president and chief financial officer, will take part in a fireside chat at 3:10 p.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY

Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

Refer to:

Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media)


Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors)

 

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-td-cowens-46th-annual-health-care-conference-302687791.html

SOURCE Eli Lilly and Company

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Eli Lilly (LLY) present at TD Cowen's 46th Annual Health Care Conference?

Lilly will present on March 2, 2026, with a fireside chat scheduled for 3:10 p.m. ET. According to the company, the session features CFO Lucas Montarce and is part of the conference program for that date.

Who will represent Eli Lilly (LLY) at the TD Cowen conference on March 2, 2026?

Lucas Montarce, executive vice president and chief financial officer, will represent Lilly in a fireside chat. According to the company, he will speak at 3:10 p.m. ET and address attendees during that session.

How can investors watch the Lilly (LLY) webcast from TD Cowen's March 2, 2026 conference?

Investors can access a live audio webcast on Lilly's investor site under Webcasts & Presentations. According to the company, the live audio stream will be available during the March 2 presentation and via the investor website.

Will a replay of Eli Lilly's (LLY) TD Cowen presentation be available after March 2, 2026?

Yes, a replay will be available on Lilly's investor website for approximately 90 days. According to the company, the replay will be posted in the same Webcasts & Presentations section after the live audio ends.

What time is the Lilly (LLY) fireside chat at TD Cowen's 46th Annual Health Care Conference?

The fireside chat is scheduled for 3:10 p.m. Eastern time on March 2, 2026. According to the company, Lucas Montarce will take part at that specific time during the conference program.

Keep reading